Search Results for keywords:"Health and Human Services Department"

The Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry have delegated authority to the Director of Strategic Business Initiatives at the CDC to sign Federal Register notices related to committee management activities and meeting announcements. For more information, contact Dr. Rashaun Roberts at the CDC.

The National Institute of Neurological Disorders and Stroke will hold a meeting of the National Advisory Neurological Disorders and Stroke Council on April 10, 2025, from 1:00 p.m. to 5:00 p.m. This meeting, which will be held virtually, is closed to the public to protect confidential information and personal privacy. The session will focus on reviewing grant applications and discussing future initiatives and other council matters. Interested individuals can submit written comments to the contact person listed in the notice at least 10 days before the meeting.

The Food and Drug Administration (FDA) is inviting the public to comment on a proposed collection of information related to its Generic Drug User Fee Program. This proposal is part of fulfilling requirements under the Paperwork Reduction Act, which mandates a 60-day public comment period for proposed information collections. Comments can be submitted online through https://www.regulations.gov or via mail by March 17, 2025. The FDA seeks feedback on the necessity, accuracy, and methods of the information collection, and aims to support the implementation of its program through the information gathered.

The Food and Drug Administration (FDA) is collecting information regarding humanitarian use devices (HUDs), which are medical devices meant for conditions affecting fewer than 8,000 people in the U.S. The FDA seeks public comments on this information collection by March 26, 2021, to help decide whether these devices should be exempt from certain effectiveness requirements. This effort is in accordance with the Paperwork Reduction Act and aims to ensure that those with rare conditions have access to necessary medical devices without significant safety risks. Additionally, the FDA updated estimates of the time and resources needed for this data collection to reflect more current information.

The Food and Drug Administration (FDA) has released a final guidance document titled "Evaluating the Public Health Importance of Food Allergens Other Than the Major Food Allergens Listed in the Federal Food, Drug, and Cosmetic Act." This guidance outlines how the FDA plans to assess the public health significance of food allergens not already classified as major allergens, like milk or peanuts. It focuses mostly on allergies caused by IgE antibodies known to trigger severe allergic reactions. The FDA also made updates in response to feedback, including changes related to non-IgE-mediated allergies and new data references.

The National Library of Medicine has announced a closed meeting on April 9, 2025. This meeting will be closed to the public because it will discuss confidential matters such as trade secrets and personal information related to grant applications. The purpose of the meeting is to review and evaluate these grant applications. It will be conducted virtually, and Dr. Ali Sharma is the contact person for any inquiries.

The document announced that the Center for Scientific Review, under the National Institutes of Health, will hold a closed meeting to discuss grant applications related to research on precision probiotic therapies. This meeting is scheduled for April 22, 2025, and will be held virtually. The session will be closed to the public to protect confidential commercial information and personal privacy. Bruce A. George is listed as the Program Analyst who issued the notice on March 13, 2025.

The Office of Refugee Resettlement (ORR), part of the Department of Health and Human Services, initially sought public comments on proposed changes to its Family Reunification Application and Sponsor Care Agreement. However, ORR has decided not to pursue these changes and is withdrawing its request for public feedback. This decision was documented in the Federal Register on January 5, 2021. Interested parties can reach out to Toby Biswas, Esq., for further information.

The National Institute of Allergy and Infectious Diseases is holding a closed virtual meeting on February 8, 2021, to review and evaluate grant applications. The meeting is closed to the public to protect confidential trade secrets, commercial property, and personal information. This session focuses on the Nonhuman Primate Reagent Resource, with no clinical trials allowed. Those interested in further details can contact Dr. Tara Capece, the Scientific Review Officer.

The Administration for Strategic Preparedness and Response (ASPR), part of the U.S. Department of Health and Human Services, is seeking public comments on the Hospital Preparedness Program (HPP) funding formula. This formula is used to distribute federal funding for health care readiness in emergencies. ASPR wants feedback particularly on the risk component of this formula, which includes factors like threat likelihood, community vulnerability, and potential consequences. People can submit their comments until December 20, 2024, and ASPR plans to use this input to consider future changes to the funding formula.